Tanisha Carino, PhD, is a health policy expert bringing over 20 years of experience driving growth and impact across multiple healthcare leadership positions in the government, private, and nonprofit sectors.

Carino most recently served as Executive Vice President, Chief Corporate Affairs Officer of Alexion, a Fortune 500 biotechnology company focused on rare disease, which was acquired by AstraZeneca. Prior to Alexion, she served as Executive Director of FasterCures, a center of the Milken Institute, a nonpartisan organization whose mission is working with global government, philanthropic, and business leaders to accelerate treatments to patients.

Previously, Carino was an executive at GlaxoSmithKline where she led the US policy function. She also spent over 10 years with Avalere Health, a strategic advisory services and business intelligence firm, and worked in the US Medicare program to improve access for its beneficiaries and support the development of real-world evidence in the establishment of national coverage determinations.

Carino is a Fulbright Fellow and earned her PhD in health policy from Johns Hopkins University. She is a member of the associate faculty at the Johns Hopkins Bloomberg School of Public Health and serves on the Board of Directors of Silk Road Medical, the National Health Council, and the Board of Directors of Alliance for Health Policy.

Conflicts of Interest

As of August 9, 2021

Financial or Business Associations:

  • AstraZeneca Pharmaceuticals, Stock

Personal Associations:

  • National Health Council, Board member
  • Alliance for Health Policy, Board member


Person Type
Panel / Committee